Delivery Order SPE2DB20D3505-SPE2DB23FU0D6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,930.30 firm-fixed price delivery order is for the supply of RABAVERT rabies vaccine with diluents. The contract has a performance period through March 27, 2024 and does not have a set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,257.48 firm fixed-price delivery order is for the supply of RABAVERT RABIES VACC W-DILUENTS, a critical medical commodity. The contract has a period of performance through March 10, 2025 and is not designated as a set-aside. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,095.80 firm fixed-price delivery order is for the supply of RABAVERT rabies vaccine with diluents. The contract has an ultimate completion date of March 20, 2025 and is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of RABAVERT RABIES VACC W-DILUENTS. The contract has a ceiling value of $3,143.70 and is a firm fixed-price delivery order placed by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of July 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $5,819.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of RABAVERT RABIES VACC W-DILUENTS, a critical pharmaceutical product, with a performance period through April 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through...
- This federal contract award, valued at $6,287.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RABAVERT RABIES VACC W-DILUENTS, a vaccine product, with an ultimate completion date of April 23, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $1,351.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of RABAVERT RABIES VACC W-DILUENTS, a pharmaceutical product, with a performance period ending on July 12, 2024. The contract has a firm-fixed-price pricing type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., involves the delivery of RABAVERT rabies vaccine with diluents. The $3,925.13 firm fixed-price delivery order was issued by the Defense Logistics Agency, a defense agency, with an ultimate completion date of April 5, 2023. The contract is not a set-aside and was awarded on a full and open competitive basis. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,474.54 Firm Fixed Price contract is for the delivery of RABAVERT Rabies Vaccine with diluents. This is a Delivery Order contract with a completion date of May 30, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support...
- This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corporation. The contract is a delivery order with a firm fixed price of $4,246.66 and an ultimate completion date of August 29, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to supply critical medical commodities to support various government...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FU0D6Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of RABAVERT RABIES VACC W-DILUENTS. The $2,948.64 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) on April 20, 2023, with a completion date of April 21, 2023. The contract is not designated with a set-aside. Amerisourcebergen holds two significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999.00 and $750,000.00 respectively. These IDCs enable Amerisourcebergen to efficiently supply a wide range of pharmaceutical products, medical supplies, and prescription drugs to support military, veterans, and other federal healthcare programs. The contract awards demonstrate Amerisourcebergen's critical role as a major pharmaceutical distributor and healthcare solutions provider to the U.S. government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 4/20/23 |